United States · Venture startup
7 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$129Mraised across 7 rounds since 2004, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $3.2M sold, first sale Sept 2015
No investor was named in the report.
From a historical funding recordSEC filing: $6.0M sold, first sale Sept 2014
No investor was named in the report.
From a historical funding record
No investor was named in the report.
Reported by sec.govSEC filing: $25M sold, first sale Mar 2010
Canaan
New Leaf Venture Partners
Wellcome TrustReported by onbiovc.comSEC filing: $15M sold, first sale May 2009
CanaanNew Leaf Venture PartnersReported by thefreelibrary.com
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
CanaanNew Leaf Venture PartnersWellcome TrustMissing a round, or an investor who was in one? Tell us.
VaxInnate's investors include Oxford Bioscience Partners, HealthCare Ventures, MedImmune Ventures, CHL Medical Partners and Canaan, and 2 more on record.
VaxInnate has raised $129M across 7 rounds since 2004.
VaxInnate's most recent round was a Venture of $3.2M in Sept 2015.
VaxInnate's largest round on record is $40M (Series C), in Oct 2006.
VaxInnate's first round on record, in Mar 2004, was backed by Oxford Bioscience Partners, HealthCare Ventures and MedImmune Ventures and 1 others.
VaxInnate's latest named round is a Venture, in Sept 2015.
VaxInnate is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
